Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Hepatocellular

Explore clinical trials studying Carcinoma, Hepatocellular. Study availability and eligibility vary by location and protocol.

2,099 public trials 531 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Hepatocellular trial results

Completed

Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer

NCT01010126

Conditions
Adenocarcinoma, Adnexal Diseases, Adult Hepatocellular Carcinoma, +76 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Tower Cancer Research Foundation Beverly Hills, California, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Los Angeles County-USC Medical Center Los Angeles, California, United States
View all 61 locations
View Trial Details
Completed

Safety, Pharmacokinetics and Preliminary Anti-Tumor Activity of Intravenous TKM-080301 in Subjects With Advanced Hepatocellular Carcinoma

NCT02191878

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +12 more
Locations
  • Arizona Clinical Research Center Tucson, Arizona, United States
  • University of California San Francisco San Francisco, California, United States
  • Kansas City Research Institute Kansas City, Missouri, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View all 15 locations
View Trial Details
Completed

Axitinib For The Treatment Of Advanced Hepatocellular Carcinoma

NCT01210495

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • Alta Bates Summit Comprehensive Cancer Center Berkeley, California, United States
  • UCSD Medical Center- La Jolla La Jolla, California, United States
  • Moores UCSD Cancer Center La Jolla, California, United States
  • University of California Irvine Medical Center Orange, California, United States
View all 77 locations
View Trial Details
Completed

Study of Mapatumumab in Combination With Sorafenib in Subjects With Advanced Hepatocellular Carcinoma

NCT01258608

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +8 more
Locations
  • GSK Investigational Site Aurora, Colorado, United States
  • GSK Investigational Site Shreveport, Louisiana, United States
  • GSK Investigational Site Rochester, Minnesota, United States
  • GSK Investigational Site Tupelo, Mississippi, United States
View all 43 locations
View Trial Details
Completed

AFP Model and Liver Transplantation.

NCT03775863

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
Locations
  • Universidad Austral Pilar, Buenos Aires, Argentina
  • Henri Mondor Hospital, University of Paris-Est. Créteil, Paris, France
View Trial Details
Completed

A Study of Ramucirumab (LY3009806) in Participants With Advanced Liver Cancer

NCT02069041

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +8 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tainan, Taiwan
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Taipei, Taiwan
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Taoyuan City, Taiwan
View Trial Details

Related conditions